Study of Etoposide in Treating Patients With Recurrent or Metastatic Breast Cancer
Status:
Unknown status
Trial end date:
2015-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether Etoposide Monotherapy is effective and safe
in the treatment of recurrent or metastatic breast cancer in Chinese female patients.
Phase:
Phase 2
Details
Lead Sponsor:
Chinese Academy of Medical Sciences
Collaborators:
Beijing Cancer Hospital Beijing Chao Yang Hospital Beijing Hospital of the Ministry of Health China-Japan Friendship Hospital Guangxi Cancer Hospital Harbin Medical University Henan Cancer Hospital International Peace Maternity and Child Health Hospital Peking Union Medical College Hospital Shanghai Putuo District Center Hospital The First Affiliated Hospital of Dalian Medical University Xinjiang Medical University Zhejiang Cancer Hospital